CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, T.
Right arrow Articles by Amaha, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, T.
Right arrow Articles by Amaha, K.
Related Collections
Right arrow General Anesthesia
Canadian Journal of Anesthesia 47:579-584 (2000)
© Canadian Anesthesiologists' Society, 2000
Laboratory Investigation

Uptake and elimination of sevoflurane in rabbit tissues - an in vivo magnetic resonance spectroscopy study

Tomoko Takeda, MD, Koshi Makita, MD, Seiji Ishikawa, MD, Koh Kaneda, MD, Kuninori Yokoyama, Be and Keisuke Amaha, MD

From the Department of Anesthesiology and Critical Care Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.

Address correspondence to: T. Tomoko MD. Phone: 81-3-5803-5323; Fax: 81-3-5803-0149; E-mail: makita.mane{at}med.tmd.ac.jp

Purpose: Previous pharmacokinetic studies of fluorinated anesthetics using 19F-magnetic resonance spectroscopy (19F-MRS) have focused on the brain. Investigation of other tissues would give more precise information about the pharmacokinetics of inhalational anesthetics. In this study we investigated the pharmacokinetics of uptake and elimination of sevoflurane in brain, liver, muscle, venous blood and arterial blood of rabbits.

Methods: Twenty rabbits were examined by 19F-MRS conducted at 4.7 Tesla using a 1-cm-diameter surface coil for brain (n=4), liver (n=5) and muscle (n=5), and a 1.3-cm-diameter surface coil for arterial (n=3) and venous (n=3) blood. Sevoflurane, 4% in oxygen, was administered for 120 min, followed by 120 min elimination.

Results: Both the uptake and elimination kinetics were best fitted by a biexponential curve which was divided into fast and slow components. During the uptake experiment the time required to reach half of the maximum spectroscopic intensity in each tissue was 1.6 min in arterial blood, 4.7 min in liver, 12.2 min in venous blood, 14.4 min in brain and 20.9 min in muscle. During the elimination experiment the time required to reach half maximum intensity was 2.4 min in arterial blood, 6.3 min in liver, 13.4 min in venous blood, 19.6 min in brain and 28.7 min in muscle.

Conclusions: Sevoflurane uptake or elimination in the tissues examined followed biexponential kinetics. In this rabbit model, sevoflurane uptake and elimination were fastest in arterial blood, followed, in order, by liver, venous blood, brain and muscle.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Canadian Anesthesiologists' Society.